126 related articles for article (PubMed ID: 12740181)
1. Evaluation on drug dependence of buprenorphine.
Liu ZM; Lü XX; Lian Z; Mu Y; Guo P; An X
Acta Pharmacol Sin; 2003 May; 24(5):448-52. PubMed ID: 12740181
[TBL] [Abstract][Full Text] [Related]
2. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
3. Drug dependence and abuse potential of tramadol.
Liu ZM; Zhou WH; Lian Z; Mu Y; Ren ZH; Cao JQ; Cai ZJ
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):52-4. PubMed ID: 10437125
[TBL] [Abstract][Full Text] [Related]
4. Assessment of differential doses of buprenorphine for long term pharmacotherapy among opiate dependent subjects.
De S; Jain R; Ray R; Dhawan A; Varghese ST
Indian J Physiol Pharmacol; 2008; 52(1):53-63. PubMed ID: 18831352
[TBL] [Abstract][Full Text] [Related]
5. Rapid detoxification of heroin dependence by buprenorphine.
Liu ZM; Cai ZJ; Wang XP; Ge Y; Li CM
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):112-4. PubMed ID: 10072959
[TBL] [Abstract][Full Text] [Related]
6. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
Blennow G; Fergusson A; Medvedeo A
Lakartidningen; 2000 Apr; 97(15):1830-3. PubMed ID: 10815411
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
Addiction; 2007 Oct; 102(10):1648-56. PubMed ID: 17854341
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
11. Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence.
White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL
Drug Alcohol Depend; 2009 Jul; 103(1-2):37-43. PubMed ID: 19403243
[TBL] [Abstract][Full Text] [Related]
12. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
Lubman D; Koutsogiannis Z; Kronborg I
Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
[TBL] [Abstract][Full Text] [Related]
13. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
15. Induction of patients with moderately severe methadone dependence onto buprenorphine.
Glasper A; Reed LJ; de Wet CJ; Gossop M; Bearn J
Addict Biol; 2005 Jun; 10(2):149-55. PubMed ID: 16191667
[TBL] [Abstract][Full Text] [Related]
16. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
17. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
[TBL] [Abstract][Full Text] [Related]
18. Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.
Wallen MC; Lorman WJ; Gosciniak JL
J Addict Dis; 2006; 25(1):23-31. PubMed ID: 16597570
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, double-dummy, randomized, prospective pilot study of the partial mu opiate agonist, buprenorphine, for acute detoxification from heroin.
Oreskovich MR; Saxon AJ; Ellis ML; Malte CA; Reoux JP; Knox PC
Drug Alcohol Depend; 2005 Jan; 77(1):71-9. PubMed ID: 15607843
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department.
Berg ML; Idrees U; Ding R; Nesbit SA; Liang HK; McCarthy ML
Drug Alcohol Depend; 2007 Jan; 86(2-3):239-44. PubMed ID: 16930865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
